Financials Autek China Inc.

Equities

300595

CNE100002MR0

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
18.06 CNY +2.21% Intraday chart for Autek China Inc. +7.63% -20.02%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 19,152 49,746 48,794 31,945 20,258 16,202 - -
Enterprise Value (EV) 1 19,152 49,746 48,186 31,067 19,278 14,388 13,940 13,298
P/E ratio 62.1 x 115 x 87.8 x 49.8 x 30.3 x 20.3 x 17.2 x 16 x
Yield 0.21% 0.11% 0.25% 0.39% 0.99% 1.32% 1.34% 1.49%
Capitalization / Revenue 29.6 x 57.1 x 37.7 x 20.9 x 11.7 x 7.8 x 6.56 x 5.73 x
EV / Revenue 29.6 x 57.1 x 37.2 x 20.4 x 11.1 x 6.92 x 5.64 x 4.7 x
EV / EBITDA - 97.7 x 66.6 x 36.7 x 21.2 x 13.8 x 11.5 x 10.4 x
EV / FCF - - - 59.1 x 36.5 x 16.1 x 15.1 x 12.8 x
FCF Yield - - - 1.69% 2.74% 6.22% 6.61% 7.81%
Price to Book 14.4 x 28.4 x 22.1 x 7.55 x 4.66 x 3.17 x 2.77 x 2.45 x
Nbr of stocks (in thousands) 849,741 850,143 850,508 894,827 897,145 897,145 - -
Reference price 2 22.54 58.51 57.37 35.70 22.58 18.06 18.06 18.06
Announcement Date 2/25/20 3/29/21 3/28/22 3/31/23 3/29/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 646.9 870.7 1,295 1,525 1,737 2,078 2,471 2,830
EBITDA 1 - 509.2 723.9 846.4 909.7 1,041 1,211 1,285
EBIT 1 333.7 474 684.6 798.5 855.7 955.4 1,180 1,283
Operating Margin 51.59% 54.44% 52.86% 52.35% 49.26% 45.98% 47.75% 45.33%
Earnings before Tax (EBT) 1 333.9 462.1 683.8 795.5 847.1 1,025 1,208 1,339
Net income 1 306.9 433.3 554.7 623.7 666.6 813.2 965.4 739.7
Net margin 47.44% 49.77% 42.84% 40.89% 38.37% 39.14% 39.07% 26.14%
EPS 2 0.3630 0.5071 0.6533 0.7163 0.7462 0.8915 1.049 1.127
Free Cash Flow 1 - - - 525.2 528.1 895 922 1,038
FCF margin - - - 34.43% 30.4% 43.07% 37.32% 36.68%
FCF Conversion (EBITDA) - - - 62.06% 58.06% 85.95% 76.16% 80.79%
FCF Conversion (Net income) - - - 84.21% 79.23% 110.06% 95.5% 140.33%
Dividend per Share 2 0.0476 0.0664 0.1460 0.1400 0.2230 0.2390 0.2425 0.2698
Announcement Date 2/25/20 3/29/21 3/28/22 3/31/23 3/29/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 298.9 371.2 313.3 526.7 314.2 401.5 378.7 539.4 417.6 464.5 482.9 687.6 532.4 - -
EBITDA 123.8 - - - - - - - - - - - - - -
EBIT 129.9 185.7 142.2 322.2 148.4 231.1 175.3 293.4 155.9 242.8 - - - - -
Operating Margin 43.47% 50.03% 45.39% 61.18% 47.22% 57.55% 46.28% 54.4% 37.34% 52.26% - - - - -
Earnings before Tax (EBT) - - - - - - - - 150.6 243 - - - - -
Net income - - - - - - - - 128.6 193 - - - - -
Net margin - - - - - - - - 30.78% 41.54% - - - - -
EPS 2 0.1300 0.1743 0.1295 0.2871 0.1300 0.1940 0.1600 0.2500 0.1500 0.2161 0.1515 0.2885 0.1386 - -
Dividend per Share 2 0.1460 - - - 0.1400 - - - 0.2230 - - - 0.1981 - -
Announcement Date 3/28/22 4/26/22 8/5/22 10/21/22 3/31/23 4/24/23 8/10/23 10/23/23 3/29/24 4/26/24 - - - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 - - 607 879 980 1,814 2,262 2,904
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - - - 525 528 895 922 1,038
ROE (net income / shareholders' equity) 26.1% 28.2% 28% 25.7% 15.6% 15.8% 15.9% 15.9%
ROA (Net income/ Total Assets) 21.7% 22.7% 21.4% - - 12.3% 12.6% 12.4%
Assets 1 1,417 1,909 2,593 - - 6,625 7,638 5,989
Book Value Per Share 2 1.570 2.060 2.600 4.730 4.850 5.690 6.530 7.360
Cash Flow per Share 2 0.3200 0.4500 0.7400 0.7300 0.8100 1.100 1.110 1.320
Capex 1 56.1 93.9 137 126 195 262 239 228
Capex / Sales 8.67% 10.78% 10.59% 8.29% 11.24% 12.62% 9.66% 8.06%
Announcement Date 2/25/20 3/29/21 3/28/22 3/31/23 3/29/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
18.06 CNY
Average target price
24.85 CNY
Spread / Average Target
+37.61%
Consensus
  1. Stock Market
  2. Equities
  3. 300595 Stock
  4. Financials Autek China Inc.